Save your place

Sign in to WhoBought

Please try again later.

Coatue Management's Moderna, Inc. (MRNA) position

Not anymore: Coatue Management fully exited MRNA in Q1 2026. The position peaked at an amount we cannot price in Q1 2021.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
200K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

MRNA price vs Management's position

Dates
$50$55$60$65← Earlier —7 purchases, 5 sells
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Exited −200K −100.0% 0 May 15, 2026
Q4 2025 New +200K 200K May 15, 2026
Q4 2024 New +191K 191K Feb 14, 2025
Q4 2023 Reduced −1.6M −33.3% 3.3M Feb 14, 2024
Q3 2023 Reduced −1.6M −25.0% 4.9M Nov 14, 2023
Q2 2023 Unchanged 6.5M Aug 14, 2023
Q1 2023 Added +153K +2.4% 6.5M May 15, 2023
Q4 2022 Added +687K +12.0% 6.4M Feb 14, 2023
Q3 2022 Added +173 0.0% 5.7M Nov 14, 2022
Q2 2022 Reduced −1.2M −17.6% 5.7M Aug 15, 2022
Q1 2022 Added +2.6M +61.6% 6.9M May 16, 2022
Q4 2021 Reduced −1.8M −29.1% 4.3M Feb 14, 2022
Q3 2021 Reduced −92K −1.5% 6.0M Nov 12, 2021
Q2 2021 Added +4.9M +388.3% 6.1M Aug 13, 2021
Q1 2021 First covered 1.3M May 14, 2021
Data through Q1 2026 · filed May 15, 2026
15 grouped rows from 15 quarters

More Management positions

Common questions

Does Coatue Management own MRNA?

Not currently. Coatue Management fully exited MRNA in Q1 2026, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Coatue Management buy MRNA?

Coatue Management held MRNA since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Coatue Management sell MRNA?

Yes. Coatue Management reduced and then fully exited MRNA by Q1 2026; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of MRNA does Coatue Management own?

None as of the latest filing: Coatue Management has exited MRNA. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Coatue Management pay for MRNA?

Coatue Management began building the MRNA position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.